A benchmark for methods in reverse engineering and model discrimination: problem formulation and solutions

Genome Research
Andreas KremlingErnst D Gilles

Abstract

A benchmark problem is described for the reconstruction and analysis of biochemical networks given sampled experimental data. The growth of the organisms is described in a bioreactor in which one substrate is fed into the reactor with a given feed rate and feed concentration. Measurements for some intracellular components are provided representing a small biochemical network. Problems of reverse engineering, parameter estimation, and identifiability are addressed. The contribution mainly focuses on the problem of model discrimination. If two or more model variants describe the available experimental data, a new experiment must be designed to discriminate between the hypothetical models. For the problem presented, the feed rate and feed concentration of a bioreactor system are available as control inputs. To verify calculated input profiles an interactive Web site (http://www.sysbio.de/projects/benchmark/) is provided. Several solutions based on linear and nonlinear models are discussed.

References

Oct 1, 1995·Applied Microbiology and Biotechnology·M J Cooney, K A McDonald
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·I SwameyeU Klingmuller
May 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jesper TegnerJames J Collins
Jun 13, 2003·Bioinformatics·M GinkelE D Gilles

❮ Previous
Next ❯

Citations

Nov 30, 2010·Bioprocess and Biosystems Engineering·Kazuhiro MaedaHiroyuki Kurata
Oct 1, 2006·Journal of Biological Physics·F J Bruggeman, H V Westerhoff
Oct 13, 2011·Bulletin of Mathematical Biology·Jason N BazilAnn E Rundell
Jun 18, 2010·Molecular BioSystems·Joshua F ApgarBruce Tidor
Feb 3, 2009·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Daniel MarbachDario Floreano
Aug 24, 2006·Bioinformatics·Zhike Zi, Edda Klipp
Dec 7, 2013·Journal of the Royal Society, Interface·Alejandro F Villaverde, Julio R Banga
May 9, 2009·BMC Bioinformatics·James Anderson, Antonis Papachristodoulou
Jun 22, 2005·BMC Bioinformatics·Kapil G GadkarFrancis J Doyle
Nov 4, 2006·BMC Bioinformatics·Maria Rodriguez-FernandezJulio R Banga
Jan 17, 2007·BMC Bioinformatics·Lars KuepferPablo A Parrilo
Feb 19, 2010·BMC Systems Biology·Eva Balsa-CantoJulio R Banga
Oct 24, 2013·BMC Systems Biology·Janusz Sławek, Tomasz Arodź
Aug 14, 2013·BMC Systems Biology·Maria Rodriguez-FernandezJulio R Banga
Jul 15, 2006·PLoS Computational Biology·Markus J HerrgårdBernhard Ø Palsson
Feb 20, 2008·PLoS Computational Biology·Joshua F ApgarBruce Tidor
Feb 27, 2010·PloS One·Robert J PrillGustavo Stolovitzky
Mar 10, 2012·PloS One·Nuno F LagesAntónio E N Ferreira
Aug 28, 2014·Bioinformatics·Nir AtiasRoded Sharan
Feb 13, 2016·Scientific Reports·Huiming PengXiaobo Zhou
Sep 27, 2014·BMC Systems Biology·Edouard PauwelsJean-Philippe Vert
Aug 8, 2009·Journal of Theoretical Biology·Thanneer M PerumalRudiyanto Gunawan
Sep 11, 2007·International Journal of Medical Informatics·Fulvia FerrazziRiccardo Bellazzi
Apr 3, 2007·Journal of Biotechnology·A Kremling, J Saez-Rodriguez
Nov 23, 2006·Trends in Microbiology·Frank J Bruggeman, Hans V Westerhoff
Nov 14, 2006·Trends in Genetics : TIG·Jesper Tegnér, Johan Björkegren
Jul 30, 2009·Molecular Systems Biology·Daniel C KirouacPeter W Zandstra
Jan 6, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Brett A McKinney
Feb 14, 2009·The FEBS Journal·Clemens Kreutz, Jens Timmer
Jul 29, 2010·Biotechnology Journal·Sang Ok SongJeffrey D Varner
Jan 8, 2013·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Ankush ChakrabartyAnn E Rundell
Sep 24, 2013·IEEE Journal of Biomedical and Health Informatics·Tao PengXiaobo Zhou
Oct 21, 2005·Bio Systems·Maria Rodriguez-FernandezJulio R Banga
Sep 22, 2015·Frontiers in Bioengineering and Biotechnology·Santiago VidelaCarito Guziolowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.